ValiRx plc (LON:VAL – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 0.55 and traded as low as GBX 0.23. ValiRx shares last traded at GBX 0.24, with a volume of 2,116,342 shares trading hands.
ValiRx Stock Performance
The company’s 50-day simple moving average is GBX 0.53 and its 200 day simple moving average is GBX 0.55. The company has a current ratio of 6.65, a quick ratio of 1.27 and a debt-to-equity ratio of 0.44. The stock has a market cap of £864,746.19, a P/E ratio of -0.25 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last released its earnings results on Monday, September 29th. The company reported GBX (0.22) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. As a group, sell-side analysts expect that ValiRx plc will post -1.74 EPS for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- What Are Earnings Reports?
- Amazon Is One of the Clearest Buys If the Market Dips Again
- Using the MarketBeat Stock Split Calculator
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- How to Use Stock Screeners to Find Stocks
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
